JAN SUNDE to Ovarian Neoplasms
This is a "connection" page, showing publications JAN SUNDE has written about Ovarian Neoplasms.
Connection Strength
0.228
-
Expression profiling identifies altered expression of genes that contribute to the inhibition of transforming growth factor-beta signaling in ovarian cancer. Cancer Res. 2006 Sep 01; 66(17):8404-12.
Score: 0.183
-
A phase I trial of oxaliplatin and topotecan in recurrent ovarian carcinoma. Gynecol Oncol. 2007 Feb; 104(2):422-7.
Score: 0.046